Proteomic identification of proteins specifically oxidized in Caenorhabditis elegans expressing human Aβ(1-42): Implications for Alzheimer’s Disease

Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes

Esterbauer, H., Schaur, R. J., & Zollner, H. (1991) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(91)90192-6 · Cited by 6,672 · see citing works

[37] Carbonyl assays for determination of oxidatively modified proteins

Levine, R. L., Williams, J. A., Stadtman, E. R., & Shacter, E. B. (1994) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(94)33040-9 · Cited by 2,707 · see citing works

Oxidative stress hypothesis in Alzheimer’s disease

Markesbery, W. R. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00629-6 · Cited by 2,383 · see citing works

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP

Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611 · see citing works

Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils

Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526 · see citing works

Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324 · see citing works

G Protein Pathways

Neves, S. R., Ram, P. T., & Iyengar, R. (2002) · Science · doi:10.1126/science.1071550 · Cited by 1,300 · see citing works

Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid β-peptide

Butterfield, D. A., Drake, J., Pocernich, C., & Castegna, A. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02173-6 · Cited by 1,114 · see citing works

Lipid peroxidation and protein oxidation in Alzheimer’s disease brain: potential causes and consequences involving amyloid β-peptide-associated free radical oxidative stress

Butterfield, D. A., & Lauderback, C. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00794-3 · Cited by 999 · see citing works

Impaired Proteasome Function in Alzheimer's Disease

Keller, J. N., Hanni, K. B., & Markesbery, W. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0750436.x · Cited by 848 · see citing works

Amyloid β-peptide (1-42)-induced Oxidative Stress and Neurotoxicity: Implications for Neurodegeneration in Alzheimer's Disease Brain. A Review

Allan Butterfield, D. (2002) · Free Radical Research · doi:10.1080/1071576021000049890 · Cited by 786 · see citing works

A Role for 4‐Hydroxynonenal, an Aldehydic Product of Lipid Peroxidation, in Disruption of Ion Homeostasis and Neuronal Death Induced by Amyloid β‐Peptide

Mark, R. J., Lovell, M. A., Markesbery, W. R., Uchida, K., & Mattson, M. P. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68010255.x · Cited by 781 · see citing works

Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation

Hensley, K., Hall, N., Subramaniam, R., Cole, P., Harris, M., Aksenov, M., Aksenova, M., Gabbita, S. P., Wu, J. F., Carney, J. M., et al. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65052146.x · Cited by 779 · see citing works

Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease

Markesbery, W. R., & Lovell, M. A. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00009-8 · Cited by 680 · see citing works

Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease

Aksenov, M. Y., & Markesbery, W. R. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01636-6 · Cited by 661 · see citing works

Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase‐related protein 2, α‐enolase and heat shock cognate 71

Castegna, A., Aksenov, M. Y., Thongboonkerd, V., Klein, J. B., Pierce, W. M. J., Booze, R. M., Markesbery, W. R., & Butterfield, D. A. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01103.x · Cited by 581 · see citing works

Proteomic identification of oxidatively modified proteins in Alzheimer’s disease brain. Part I: Creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1

Castegna, A., Aksenov, M., Aksenova, M., Thongboonkerd, V., Klein, J. B., Pierce, W. M., Booze, R., Markesbery, W. R., & Butterfield, D. A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00914-0 · Cited by 581 · see citing works

The Protein Kinase C Family for Neuronal Signaling

Tanaka, C., & Nishizuka, Y. (1994) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.17.030194.003003 · Cited by 543 · see citing works

Proteomic identification of nitrated proteins in Alzheimer's disease brain

Castegna, A., Thongboonkerd, V., Klein, J. B., Lynn, B. C., Markesbery, W. R., & Butterfield, D. A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01786.x · Cited by 535 · see citing works

Protein oxidation in the brain in Alzheimer's disease

Aksenov, M. Y., Aksenova, M. V., Butterfield, D. A., Geddes, J. W., & Markesbery, W. R. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00580-7 · Cited by 503 · see citing works

Deficient glutamate tranport is associated with neurodegeneration in Alzheimer's disease

Masliah, E., Hansen, L., Alford, M., Deteresa, R., & Mallory, M. (1996) · Annals of Neurology · doi:10.1002/ana.410400512 · Cited by 476 · see citing works

The glial glutamate transporter, GLT‐1, is oxidatively modified by 4‐hydroxy‐2‐nonenal in the Alzheimer's disease brain: the role of Aβ1–42

Lauderback, C. M., Hackett, J. M., Huang, F. F., Keller, J. N., Szweda, L. I., Markesbery, W. R., & Butterfield, D. A. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00451.x · Cited by 464 · see citing works

Regional Membrane Phospholipid Alterations in Alzheimer's Disease

Prasad, M. R., Lovell, M. A., Yatin, M., Dhillon, H. S., & Markesbery, W. R. (1998) · Neurochemical Research · doi:10.1023/a:1022457605436 · Cited by 440 · see citing works

Reduced Activities of Thiamine-Dependent Enzymes in the Brains and Peripheral Tissues of Patients With Alzheimer's Disease

Gibson, G. E., Sheu, K. ‐. R., Blass, J. P., Baker, A., Carlson, K., Harding, B. N., & Perrino, P. (1988) · Archives of Neurology · doi:10.1001/archneur.1988.00520320022009 · Cited by 425 · see citing works

Chapter 7 Protein Oxidation Processes in Aging Brain

Butterfield, D. A., & Stadtman, E. R. (1997) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(08)60057-7 · Cited by 390 · see citing works

Oxidative stress precedes fibrillar deposition of Alzheimer's disease amyloid β-peptide (1–42) in a transgenic Caenorhabditis elegans model

Drake, J. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00225-7 · Cited by 371 · see citing works

Synaptic and neuritic alterations during the progression of Alzheimer's disease

Masliah, E., Mallory, M., Hansen, L., Richard, D., Alford, M., & Terry, R. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90121-x · Cited by 370 · see citing works

The Molecular and Genetic Basis of Neurological Disease

Trojanowski, J. Q. (1993) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199309000-00013 · Cited by 341 · see citing works

Amyloid β peptide induces tau phosphorylation and loss of cholinergic neurons in rat primary septal cultures

Zheng, W.-H., Bastianetto, S., Mennicken, F., Ma, W., & Kar, S. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00404-9 · Cited by 321 · see citing works

Gene expression analysis in a transgenic Caenorhabditis elegans Alzheimer's disease model

Link, C. D. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00224-5 · Cited by 301 · see citing works

Oxidative Modification of Creatine Kinase BB in Alzheimer’s Disease Brain

Aksenov, M. Y., Aksenova, M. V., Butterfield, D. A., & Markesbery, W. R. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742520.x · Cited by 286 · see citing works

Aggregation-related toxicity of synthetic β-amyloid protein in hippocampal cultures

Pike, C. J., Walencewicz, A. J., Glabe, C. G., & Cotman, C. W. (1991) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(91)90014-9 · Cited by 276 · see citing works

Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease

Lovell, M. A., Xie, C., & Markesbery, W. R. (1998) · Neurology · doi:10.1212/wnl.51.6.1562 · Cited by 275 · see citing works

The Lipid Peroxidation Product, 4‐Hydroxy‐2‐<i>trans</i>‐Nonenal, Alters the Conformation of Cortical Synaptosomal Membrane Proteins

Subramaniam, R., Roediger, F., Jordan, B., Mattson, M. P., Keller, J. N., Waeg, G., & Butterfield, D. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031161.x · Cited by 270 · see citing works

Transition state structure of arginine kinase: Implications for catalysis of bimolecular reactions

Zhou, G., Somasundaram, T., Blanc, E., Parthasarathy, G., Ellington, W. R., & Chapman, M. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8449 · Cited by 241 · see citing works

Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain

Butterfield, D. A. (2004) · Brain Research · doi:10.1016/j.brainres.2003.12.012 · Cited by 210 · see citing works

Proteasome Inhibition Alters Neural Mitochondrial Homeostasis and Mitochondria Turnover

Sullivan, P. G., Dragicevic, N., Deng, J., Bai, Y., Dimayuga, E. R., Ding, Q., Chen, Q., Bruce‐Keller, A. J., & Keller, J. N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313579200 · Cited by 202 · see citing works

A stress-responsive glutathione S-transferase confers resistance to oxidative stress in Caenorhabditis elegans

Leiers, B., Kampkötter, A., Grevelding, C. G., Link, C. D., Johnson, T. E., & Henkle‐Dührsen, K. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00102-3 · Cited by 199 · see citing works

A distinctive role for the Yersinia protein kinase: Actin binding, kinase activation, and cytoskeleton disruption

Juris, S., Rudolph, A. E., Huddler, D., Orth, K., & Dixon, J. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170281997 · Cited by 199 · see citing works

Biomedical informatics for proteomics

Boguski, M. S., & McIntosh, M. W. (2003) · Nature · doi:10.1038/nature01515 · Cited by 178 · see citing works

The Molecular and Genetic Basis of Neurological Disease.

BARKER, R. (1998) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.5.806a · Cited by 158 · see citing works

Oxidatively Modified GST and MRP1 in Alzheimer?s Disease Brain: Implications for Accumulation of Reactive Lipid Peroxidation Products

Sultana, R., & Butterfield, D. A. (2004) · Neurochemical Research · doi:10.1007/s11064-004-7028-0 · Cited by 153 · see citing works

Amyloid β-Peptide [1-42]-Associated Free Radical-Induced Oxidative Stress And Neurodegeneration in Alzheimers Disease Brain: Mechanisms and Consequences

Butterfield, D. A. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033456422 · Cited by 149 · see citing works

The Expression of Several Mitochondrial and Nuclear Genes Encoding the Subunits of Electron Transport Chain Enzyme Complexes, Cytochrome c Oxidase, and NADH Dehydrogenase, in Different Brain Regions in Alzheimer's Disease

Aksenov, M. Y., Tucker, H. M., Nair, P., Aksenova, M. V., Butterfield, D. A., Estus, S., & Markesbery, W. R. (1999) · Neurochemical Research · doi:10.1023/a:1020783614031 · Cited by 102 · see citing works

Fluoride Exposure Attenuates Expression of Streptococcus pyogenes Virulence Factors

Thongboonkerd, V., Luengpailin, J., Cao, J., Pierce, W. M. J., Cai, J., Klein, J. B., & Doyle, R. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200746200 · Cited by 102 · see citing works

Arginine kinase evolved twice: evidence that echinoderm arginine kinase originated from creatine kinase

Suzuki, T., Kamidochi, M., INOUE, N., Kawamichi, H., Yazawa, Y., Furukohri, T., & Ellington, W. R. (1999) · Biochemical Journal · doi:10.1042/bj3400671 · Cited by 99 · see citing works

Invertebrate models of Alzheimer's disease

Link, C. D. (2004) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2004.00105.x · Cited by 97 · see citing works

Proteomic analysis of brain proteins in the gracile axonal dystrophy (gad) mouse, a syndrome that emanates from dysfunctional ubiquitin carboxyl‐terminal hydrolase L‐1, reveals oxidation of key proteins

Castegna, A., Thongboonkerd, V., Klein, J. B., Lynn, B. C., Wang, Y., Osaka, H., Wada, K., & Butterfield, D. A. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02288.x · Cited by 89 · see citing works

The spectrin-based membrane skeleton as a membrane protein-sorting machine

Beck, K. A., & Nelson, W. J. (1996) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.1996.270.5.c1263 · Cited by 87 · see citing works

Protein kinase C anchoring deficit in postmortem brains of Alzheimer's disease patients.

Battaini, F., Pascale, A., Lucchi, L., Pasinetti, G., & Govoni, S. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7151 · Cited by 82 · see citing works

The role of phosphagen specificity loops in arginine kinase

Azzi, A., Clark, S. A., Ellington, W. R., & Chapman, M. S. (2004) · Protein Science · doi:10.1110/ps.03428304 · Cited by 78 · see citing works

Contribution of neuroimaging in the diagnosis of Alzheimerʼs disease and other dementias

Scheltens, P., & Korf, E. S. C. (2000) · Current Opinion in Neurology · doi:10.1097/00019052-200008000-00005 · Cited by 72 · see citing works

Glutathione transferase protects neuronal cultures against four hydroxynonenal toxicity

Xie, C., Lovell, M. A., & Markesbery, W. R. (1998) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00186-5 · Cited by 72 · see citing works

Glucose intolerance, cognitive impairment and Alzheimer’s disease

Vanhanen, M., & Soininen, H. S. (1998) · Current Opinion in Neurology · doi:10.1097/00019052-199812000-00011 · Cited by 72 · see citing works

Cholesterol Modulates Amyloid Beta-peptide’s Membrane Interactions

Eckert, G. P., Kirsch, C., Leutz, S., Wood, W. G., & Müller, W. E. (2003) · Pharmacopsychiatry · doi:10.1055/s-2003-43059 · Cited by 59 · see citing works

Comparison of Statistical Approaches for the Analysis of Proteome Expression Data of Differentiating Neural Stem Cells

Maurer, M. H., Feldmann, R., Brömme, J. O., & Kalenka, A. (2004) · Journal of Proteome Research · doi:10.1021/pr049841l · Cited by 55 · see citing works

Glucose regulation and brain aging.

Messier, C., & Gagnon, M. (2000) · PubMed · Cited by 43 · see citing works

Protein–protein interactions among human 20S proteasome subunits and proteassemblin

Jayarapu, K., & Griffin, T. A. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.119 · Cited by 28 · see citing works

Caenorhabditis elegans: An Emerging Model in Biomedical and Environmental Toxicology

Leung, M. C. K., Williams, P. L., Benedetto, A., Au, C., Helmcke, K. J., Aschner, M., & Meyer, J. N. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn121 · Cited by 1,027 · see citing works

Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis in the Last Decade

Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 603 · see citing works

Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer's disease and mild cognitive impairment

Butterfield, D. A., Reed, T., Newman, S. F., & Sultana, R. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.05.037 · Cited by 564 · see citing works

Amyloid <i>β</i> -Peptide (1–42)-Induced Oxidative Stress in Alzheimer Disease: Importance in Disease Pathogenesis and Progression

Butterfield, D. A., Swomley, A. M., & Sultana, R. (2013) · Antioxidants &amp; Redox Signaling · doi:10.1089/ars.2012.5027 · Cited by 526 · see citing works

Proteomics: Challenges, Techniques and Possibilities to Overcome Biological Sample Complexity

Chandramouli, K., & Qian, P. (2009) · Human Genomics and Proteomics · doi:10.4061/2009/239204 · Cited by 514 · see citing works

Oxidative Stress in Neurodegenerative Diseases: From a Mitochondrial Point of View

Cenini, G., Lloret, A., & Cascella, R. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2105607 · Cited by 435 · see citing works

Oxidative Stress, Amyloid-β Peptide, and Altered Key Molecular Pathways in the Pathogenesis and Progression of Alzheimer’s Disease

Butterfield, D. A., & Boyd-Kimball, D. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170543 · Cited by 403 · see citing works

Redox proteomics identification of oxidized proteins in Alzheimer's disease hippocampus and cerebellum: An approach to understand pathological and biochemical alterations in AD

Rukhsana Sultana, A., Debra Boyd-kimball, A., Poon, H. F., Cai, J., Pierce, W. M. J., Klein, J. B., Merchant, M. L., Markesbery, W. R., & Butterfield, D. A. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.021 · Cited by 334 · see citing works

Role of Oxidative Stress in the Progression of Alzheimer's Disease

Rukhsana Sultana, A., & Butterfield, D. A. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1222 · Cited by 327 · see citing works

Oxidative stress and β-amyloid protein in Alzheimer’s disease

Cai, Z., Zhao, B., & Ratka, A. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-011-8155-9 · Cited by 279 · see citing works

Redox proteomic identification of 4-Hydroxy-2-nonenal-modified brain proteins in amnestic mild cognitive impairment: Insight into the role of lipid peroxidation in the progression and pathogenesis of Alzheimer's disease

Reed, T., Perluigi, M., Sultana, R., Pierce, W. M., Klein, J. B., Turner, D. M., Coccia, R., Markesbery, W. R., & Butterfield, D. A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.12.007 · Cited by 257 · see citing works

Nitrosative Stress, Cellular Stress Response, and Thiol Homeostasis in Patients with Alzheimer's Disease

Calabrese, V., Rukhsana Sultana, A., Scapagnini, G., Guagliano, E., Sapienza, M. A., Bella, R., Kański, J., Pennisi, G., Mancuso, C., Stella, A. M. G., et al. (2006) · Antioxidants and Redox Signaling · doi:10.1089/ars.2006.8.1975 · Cited by 227 · see citing works

C. elegans models of age-associated neurodegenerative diseases: Lessons from transgenic worm models of Alzheimer’s disease

Link, C. D. (2006) · Experimental Gerontology · doi:10.1016/j.exger.2006.06.059 · Cited by 213 · see citing works

Protein Targets of Oxidative Damage in Human Neurodegenerative Diseases with Abnormal Protein Aggregates

Martínez, A., Portero‐Otín, M., Pamplona, R., & Ferrer, I. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00326.x · Cited by 213 · see citing works

Impaired vascular-mediated clearance of brain amyloid beta in Alzheimer’s disease: the role, regulation and restoration of LRP1

Ramanathan, A., Nelson, A. R., Sagare, A. P., & Zlokovic, B. V. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00136 · Cited by 205 · see citing works

Oxidatively modified proteins in Alzheimer’s disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis

Sultana, R., Perluigi, M., & Butterfield, D. A. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0517-0 · Cited by 215 · see citing works

Abeta, oxidative stress in Alzheimer disease: Evidence based on proteomics studies

Swomley, A. M., Förster, S., Keeney, J. T. R., Triplett, J. C., Zhang, Z., Rukhsana Sultana, A., & Butterfield, D. A. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.09.015 · Cited by 190 · see citing works

Alterations in brain antioxidant enzymes and redox proteomic identification of oxidized brain proteins induced by the anti-cancer drug adriamycin: implications for oxidative stress-mediated chemobrain

Gururaj Joshi, A., Aluise, C. D., Cole, M. P., Rukhsana Sultana, A., Pierce, W. M. J., Vore, M. E., Clair, D. K. S., & Butterfield, D. A. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.01.021 · Cited by 156 · see citing works

The Caenorhabditis elegans Aβ1–42 Model of Alzheimer Disease Predominantly Expresses Aβ3–42

McColl, G., Roberts, B. R., Gunn, A. P., Perez, K. A., Tew, D. J., Masters, C. L., Barnham, K. J., Cherny, R. A., & Bush, A. I. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.c109.028514 · Cited by 131 · see citing works

The 2013 SFRBM Discovery Award: Selected discoveries from the Butterfield laboratory of oxidative stress and its sequela in brain in cognitive disorders exemplified by Alzheimer disease and chemotherapy induced cognitive impairment

Butterfield, D. A. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.06.006 · Cited by 126 · see citing works

Decreased Insulin-Receptor Signaling Promotes the Autophagic Degradation of β-Amyloid Peptide inC. elegans

Florez‐McClure, M. L., Hohsfield, L. A., Fonte, G., Bealor, M. T., & Link, C. D. (2007) · Autophagy · doi:10.4161/auto.4776 · Cited by 123 · see citing works

Mass spectrometry and redox proteomics: Applications in disease

Butterfield, D. A., Gu, L., Domenico, F. D., & Robinson, R. A. S. (2013) · Mass Spectrometry Reviews · doi:10.1002/mas.21374 · Cited by 113 · see citing works

Redox proteomics and amyloid β-peptide: Insights into Alzheimer disease

Butterfield, D. A., & Boyd‐Kimball, D. (2019) · Journal of Neurochemistry · doi:10.1111/jnc.14589 · Cited by 105 · see citing works

Brain lipid peroxidation and alzheimer disease: Synergy between the Butterfield and Mattson laboratories

Butterfield, D. A. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101049 · Cited by 97 · see citing works

Energy crisis precedes global metabolic failure in a novel Caenorhabditis elegans Alzheimer Disease model

Fong, S., Teo, E., Ng, L. F., Chen, C.-B., Lakshmanan, L. N., Tsoi, S. Y., Moore, P. K., Inoue, T., Halliwell, B. B., & Gruber, J. (2016) · Scientific Reports · doi:10.1038/srep33781 · Cited by 93 · see citing works

Mitochondrial Oxidative and Nitrosative Stress and Alzheimer Disease

Butterfield, D. A., & Boyd-Kimball, D. (2020) · Antioxidants · doi:10.3390/antiox9090818 · Cited by 85 · see citing works

Protein carbonylation: Proteomics, specificity and relevance to aging

Cabiscol, E., Tamarit, J., & Ros, J. (2013) · Mass Spectrometry Reviews · doi:10.1002/mas.21375 · Cited by 81 · see citing works

Oxidative damage in brain from human mutant APP/PS-1 double knock-in mice as a function of age

Abdul, H. M., Rukhsana Sultana, A., Clair, D. K. S., Markesbery, W. R., & Butterfield, D. A. (2008) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2008.08.012 · Cited by 81 · see citing works

Proteomics in animal models of Alzheimer's and Parkinson's diseases

Robinson, R. A. S., Owen, J. B., & Butterfield, D. A. (2008) · Ageing Research Reviews · doi:10.1016/j.arr.2008.07.003 · Cited by 81 · see citing works

Proteins that mediate protein aggregation and cytotoxicity distinguish Alzheimer's hippocampus from normal controls

Ayyadevara, S., Balasubramaniam, M., Parcon, P. A., Barger, S. W., Griffin, W. S. T., Alla, R., Tackett, A. J., Mackintosh, S. G., Petricoin, E. F., Zhou, W., et al. (2016) · Aging Cell · doi:10.1111/acel.12501 · Cited by 76 · see citing works

Cellular stress response, sirtuins and UCP proteins in Alzheimer disease: role of vitagenes

Cornelius, C., Salinaro, A. T., Scuto, M. C., Fronte, V., Cambria, M. T., Pennisi, M., Bella, R., Milone, P., Graziano, A., Crupi, R., et al. (2013) · Immunity & Ageing · doi:10.1186/1742-4933-10-41 · Cited by 73 · see citing works

Redox proteomics identification of specifically carbonylated proteins in the hippocampi of triple transgenic Alzheimer’s disease mice at its earliest pathological stage

Shen, L., Chen, C., Yang, A., Chen, Y., Liu, Q., & Ni, J. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.04.005 · Cited by 73 · see citing works

Metabolic stress is a primary pathogenic event in transgenic Caenorhabditis elegans expressing pan-neuronal human amyloid beta

Teo, E., Ravi, S., Barardo, D., Kim, H.-S., Fong, S., Cazenave-Gassiot, A., Tan, T. Y., Ching, J., Kovalik, J.-P., Wenk, M. R., et al. (2019) · eLife · doi:10.7554/elife.50069 · Cited by 72 · see citing works

Oxidative stress damage and oxidative stress responses in the choroid plexus in Alzheimer’s disease

Perez-Gracia, E., Blanco, R., Carmona, M., Carro, E., & Ferrer, I. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0574-4 · Cited by 63 · see citing works

Altered angiotensin-converting enzyme and its effects on the brain in a rat model of Alzheimer disease

Hou, D., Wang, Y., Zhou, L., Chen, K., Tian, Y., Song, Z. J., Juan, B. A. O., & Yang, Q. (2008) · Chinese Medical Journal · doi:10.1097/00029330-200811020-00019 · Cited by 64 · see citing works

Effects of ageing and Alzheimer’s disease on mitochondrial function of human platelets

Shi, C., Guo, K., Yew, D. T. W., Yao, Z., Forster, E. L., Wang, H., & Xu, J. (2008) · Experimental Gerontology · doi:10.1016/j.exger.2008.02.004 · Cited by 62 · see citing works

Cinnamomum cassia Bark in Two Herbal Formulas Increases Life Span in Caenorhabditis elegans via Insulin Signaling and Stress Response Pathways

Yu, Y.-B., Dosanjh, L. E., Lao, L., Tan, M., Shim, B. S., & Luo, Y. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009339 · Cited by 59 · see citing works

ATP synthase and Alzheimer’s disease: putting a spin on the mitochondrial hypothesis

Ebanks, B., Ingram, T. L., & Chakrabarti, L. (2020) · Aging · doi:10.18632/aging.103867 · Cited by 58 · see citing works

Protective Role of DNJ-27/ERdj5 in Caenorhabditis elegans Models of Human Neurodegenerative Diseases

Muñoz-Lobato, F., Rodríguez‐Palero, M. J., Naranjo-Galindo, F. J., Shephard, F., Gaffney, C. J., Szewczyk, N. J., Hamamichi, S., Caldwell, K. A., Caldwell, G. A., Link, C. D., et al. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.5051 · Cited by 56 · see citing works

Mitochondrial ATP Synthase is a Target of Oxidative Stress in Neurodegenerative Diseases

Ebanks, B., & Chakrabarti, L. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.854321 · Cited by 56 · see citing works

Applications and current challenges of proteomic approaches, focusing on two-dimensional electrophoresis

Vercauteren, F., Arckens, L., & Quirion, R. (2006) · Amino Acids · doi:10.1007/s00726-006-0460-5 · Cited by 54 · see citing works

Heat shock treatment reduces beta amyloid toxicity in vivo by diminishing oligomers

Wu, Y., Cao, Z., Klein, W. L., & Luo, Y. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.07.013 · Cited by 53 · see citing works

Redox Proteomics Analyses of the Influence of Co-Expression of Wild-Type or Mutated LRRK2 and Tau on C. elegans Protein Expression and Oxidative Modification: Relevance to Parkinson Disease

Domenico, F. D., Rukhsana Sultana, A., Ferree, A. W., Smith, K., Barone, E., Marzia Perluigi, A., Coccia, R., Pierce, W. M. J., Cai, J., Mancuso, C., et al. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4312 · Cited by 51 · see citing works

Watching Worms Whither: Modeling Neurodegeneration in C. elegans

Wolozin, B., Gabel, C. V., Ferree, A., Guillily, M. D., & Ebata, A. (2011) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-384878-9.00015-7 · Cited by 56 · see citing works

Molecular Characterisation of Colour Formation in the Prawn Fenneropenaeus merguiensis

Ertl, N. G., Elizur, A., Brooks, P. R., Kuballa, A., Anderson, T. A., & Knibb, W. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056920 · Cited by 47 · see citing works

Proteomics of Alzheimer’s disease: understanding mechanisms and seeking biomarkers

Lovestone, S., Güntert, A., Hye, A., Lynham, S., Thambisetty, M., & Ward, M. A. (2007) · Expert Review of Proteomics · doi:10.1586/14789450.4.2.227 · Cited by 46 · see citing works

Stress and Alzheimer’s disease

Escher, C. M., Sannemann, L., & Jessen, F. (2019) · Journal of Neural Transmission · doi:10.1007/s00702-019-01988-z · Cited by 44 · see citing works

Protein Oxidation in Aging and Alzheimer’s Disease Brain

Rukhsana Sultana, A., & Butterfield, D. A. (2024) · Antioxidants · doi:10.3390/antiox13050574 · Cited by 42 · see citing works

Redox proteomics in some age-related neurodegenerative disorders or models thereof

Butterfield, D. A., Abdul, H. M., Newman, S. F., & Reed, T. T. (2006) · NeuroRx · doi:10.1016/j.nurx.2006.05.003 · Cited by 37 · see citing works

Metabolic profiling of a transgenic Caenorhabditis elegans Alzheimer model

Assche, R. V., Temmerman, L., Dias, D. A., Boughton, B. A., Boonen, K., Braeckman, B. P., Schoofs, L., & Roessner, U. (2014) · Metabolomics · doi:10.1007/s11306-014-0711-5 · Cited by 35 · see citing works

Proteomics of spermatogenesis: from protein lists to understanding the regulation of male fertility and infertility

Huang, X., & Sha, J. (2010) · Asian Journal of Andrology · doi:10.1038/aja.2010.71 · Cited by 33 · see citing works

Genetic aspects of behavioral neurotoxicology

Levin, E. D., Aschner, M., Heberlein, U., Ruden, D. M., Welsh-Bohmer, K. A., Bartlett, S. E., Berger, K. H., Chen, L., Corl, A. B., Eddins, D. M., et al. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.07.014 · Cited by 32 · see citing works

Proteomics Identification of Carbonylated and HNE-Bound Brain Proteins in Alzheimer’s Disease

Rukhsana Sultana, A., & Butterfield, D. A. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-562-6_9 · Cited by 31 · see citing works

Proteomics Analysis in Alzheimer's Disease: New Insights into Mechanisms of Neurodegeneration

Butterfield, D. A., & Debra Boyd-kimball, A. (2004) · International review of neurobiology · doi:10.1016/s0074-7742(04)61007-5 · Cited by 31 · see citing works

Effect of ionizing radiation on liver protein oxidation and metabolic function in C57BL/6J mice

Barshishat-Küpper, M., Tipton, A. J., McCart, E. A., McCue, J. M., Mueller, G. P., & Day, R. M. (2014) · International Journal of Radiation Biology · doi:10.3109/09553002.2014.930536 · Cited by 30 · see citing works

Ubiquitin carboxyl-terminal hydrolase L-1 in brain: Focus on its oxidative/nitrosative modification and role in brains of subjects with Alzheimer disease and mild cognitive impairment

Butterfield, D. A. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.10.036 · Cited by 30 · see citing works

Oxidative Stress in Brain in Amnestic Mild Cognitive Impairment

Butterfield, D. A. (2023) · Antioxidants · doi:10.3390/antiox12020462 · Cited by 28 · see citing works

Autophagy and cell death in Caenorhabditis elegans.

Samara, C., & Tavernarakis, N. (2008) · Current pharmaceutical design · doi:10.2174/138161208783378770 · Cited by 27 · see citing works

New Proteins Found Interacting with Brain Metallothionein‐3 Are Linked to Secretion

Ghazi, I. E., Martin, B. L., & Armitage, I. M. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2011/208634 · Cited by 25 · see citing works

Gene–environment interactions: Neurodegeneration in non-mammals and mammals

Aschner, M., Levin, E. D., Sunol, C. E., Olopade, J. O., Helmcke, K. J., Ávila, D. S., Sledge, D., Ali, R. H., Upchurch, L. M., & Donerly, S. (2010) · NeuroToxicology · doi:10.1016/j.neuro.2010.03.008 · Cited by 25 · see citing works

Redox proteomics studies of in vivo amyloid beta‐peptide animal models of Alzheimer's disease: Insight into the role of oxidative stress

Rukhsana Sultana, A., & Butterfield, D. A. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200780024 · Cited by 23 · see citing works

Proteomic Analysis of Lymphoblastoid Cells from Nasu-Hakola Patients: A Step Forward in Our Understanding of This Neurodegenerative Disorder

Giuliano, S., Agresta, A. M., Palma, A. D., Viglio, S., Mauri, P., Fumagalli, M., Iadarola, P., Montalbetti, L., Salvini, R., & Bardoni, A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110073 · Cited by 21 · see citing works

Oxidative Stress in Alzheimer Disease: Synergy Between the Butterfield and Markesbery Laboratories

Butterfield, D. A. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8123-9 · Cited by 22 · see citing works

Caenorhabditis elegans proteomics comes of age

Shim, Y., & Paik, Y. (2009) · PROTEOMICS · doi:10.1002/pmic.200900542 · Cited by 21 · see citing works

AROS-29 is involved in adaptive response to oxidative stress

Gesualdi, N. M., Chirico, G., Catanese, M. T., Pirozzi, G., & Esposito, F. (2006) · Free Radical Research · doi:10.1080/10715760600570547 · Cited by 20 · see citing works

Multiple measures of functionality exhibit progressive decline in a parallel, stochastic fashion in Drosophila Sod2 null mutants

Piazza, N., Hayes, M., Martin, I., Duttaroy, A., Grotewiel, M., & Wessells, R. J. (2009) · Biogerontology · doi:10.1007/s10522-008-9210-2 · Cited by 19 · see citing works

Inclusion Body Myositis: A View from the Caenorhabditis elegans Muscle

Rebolledo, D. L., Minniti, A. N., Grez, P. M., Fadić, R., Kohn, R. E., & Inestrosa, N. C. (2008) · Molecular Neurobiology · doi:10.1007/s12035-008-8041-0 · Cited by 16 · see citing works

Lack of p53 Affects the Expression of Several Brain Mitochondrial Proteins: Insights from Proteomics into Important Pathways Regulated by p53

Fiorini, A., Sultana, R., Barone, E., Cenini, G., Perluigi, M., Mancuso, C., Cai, J., Klein, J. B., St. Clair, D., & Butterfield, D. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049846 · Cited by 16 · see citing works

Dynamic Interplay between Copper Toxicity and Mitochondrial Dysfunction in Alzheimer’s Disease

Tassone, G., Kola, A., Valensin, D., & Pozzi, C. (2021) · Life · doi:10.3390/life11050386 · Cited by 16 · see citing works

A New Insight into an Alternative Therapeutic Approach to Restore Redox Homeostasis and Functional Mitochondria in Neurodegenerative Diseases

Hyun, D., & Lee, J. (2021) · Antioxidants · doi:10.3390/antiox11010007 · Cited by 14 · see citing works

Identification of proteins containing redox-sensitive thiols after PRDX1, PRDX3 and GCLC silencing and/or glucose oxidase treatment in Hepa 1–6 cells

Fuentes-Almagro, C. A., Prieto‐Álamo, M., Pueyo, C., & Jurado, J. (2012) · Journal of Proteomics · doi:10.1016/j.jprot.2012.08.025 · Cited by 13 · see citing works

DMT1 knockout abolishes ferroptosis induced mitochondrial dysfunction in C. elegans amyloid β proteotoxicity

Peng, W., Chung, K. B., Lawrence, B. P., O’Banion, M. K., Dirksen, R. T., Wojtovich, A. P., & Onukwufor, J. O. (2024) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2024.09.034 · Cited by 11 · see citing works

Using Caenorhabditis elegans Models of Neurodegenerative Disease to Identify Neuroprotective Strategies

Kraemer, B. C., & Schellenberg, G. D. (2006) · International review of neurobiology · doi:10.1016/s0074-7742(06)77007-6 · Cited by 11 · see citing works

Changes of hippocampus proteomic profiles after blueberry extracts supplementation in APP/PS1 transgenic mice

Li, H., Tan, L., Yang, H., Pang, W., Xu, T., & Jiang, Y.-G. (2018) · Nutritional Neuroscience · doi:10.1080/1028415x.2018.1471251 · Cited by 10 · see citing works

Proteomics‐based investigations of animal models of disease

Bousette, N., Gramolini, A. O., & Kislinger, T. (2008) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.200780043 · Cited by 10 · see citing works

Effects ofβ-amyloid peptide and estrogen on platelet mitochondrial function of Sprague-Dawley rats

Xu, J., Shi, C., Li, Q., Lam, W. P., Wai, M. S. M., & Yew, D. T. W. (2007) · Platelets · doi:10.1080/09537100701206808 · Cited by 9 · see citing works

A Shotgun Proteomic Platform for a Global Mapping of Lymphoblastoid Cells to Gain Insight into Nasu-Hakola Disease

Palma, A. D., Agresta, A. M., Viglio, S., Rossi, R., D’Amato, M., Silvestre, D. D., Mauri, P., & Iadarola, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189959 · Cited by 7 · see citing works

Common Proteomic Technologies, Applications, and their Limitations

Meyfour, A., Rezaei–Tavirani, M., & Sadeghi, M. R. (2013) · Archives of Advances in Biosciences · doi:10.22037/jps.v4i0.4014 · Cited by 6 · see citing works

Potential Uses of Mushrooms as Dietary Supplement to Enhance Memory

Arya, C. (2022) · Springer eBooks · doi:10.1007/978-981-16-6257-7_13 · Cited by 5 · see citing works

Amyloid β-Peptide(1-42), Oxidative Stress, and Alzheimer’s Disease

Butterfield, D. A. (2006) · Springer eBooks · doi:10.1007/978-1-84628-440-3_5 · Cited by 4 · see citing works

Redox proteomics in some age-related neurodegenerative disorders or models thereof

Butterfield, D. A., Abdul, H. M., Newman, S. F., & Reed, T. T. (2006) · Neurotherapeutics · doi:10.1007/bf03206658 · Cited by 4 · see citing works

Protein Oxidation and Aging: Different Model Systems and Affecting Factors

Grune, T., Karademir-Yilmaz, B., & Jung, T. (2012) · Wiley eBooks · doi:10.1002/9781118493038.ch3 · Cited by 4 · see citing works

C. elegans and Neurodegeneration In Caenorhabditis Elegans: Anatomy, Life Cycles and Biological Functions.

Martinez‐Finley, E. J., Chakraborty, S., Caito, S., Fretham, S. J. B., & Aschner, M. (2012) · PubMed · Cited by 2 · see citing works

Serpins in Caenorhabditis elegans

Luke, C. J., Miedel, M. T., O’Reilly, L. P., Wyatt, A. N., Knoerdel, R. R., Pak, S. C., & Silverman, G. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-22711-5_15 · Cited by 2 · see citing works

Redox Proteomics and Metabolic Proteins in Brain of Subjects with Alzheimer's Disease, Mild Cognitive Impairment, and Models Thereof

Rukhsana Sultana, A., Reed, T. T., & Butterfield, D. A. (2008) · doi:10.1002/9783527622467.ch9 · Cited by 2 · see citing works

BACTERIAL INFECTION ALTERS PROTEOME OF CAENORHABDITIS ELEGANS

Balamurugan, K. (2013) · Journal of Proteins and Proteomics · Cited by 1 · see citing works

Caenorhabditis elegans Models of Human Neurodegenerative Diseases

Nass, R., & Chen, L. (2008) · Humana Press eBooks · doi:10.1007/978-1-59745-285-4_12 · Cited by 1 · see citing works

Redox Proteomics Identification of Oxidatively Modified Proteins in Alzheimer’s Disease Brain and in Brain from a Rodent Model of Familial Parkinson’s Disease: Insights into Potential Mechanisms of Neurodegeneration

Rukhsana Sultana, A., Poon, H. F., & Butterfield, D. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-72076-0_15 · Cited by 1 · see citing works

IN VIVO OXIDATIVE STRESS IN ALZHEIMER DISEASE BRAIN AND A MOUSE MODEL THEREOF: EFFECTS OF LIPID ASYMMETRY AND THE SINGLE METHIONINE RESIDUE OF AMYLOID-β PEPTIDE

Lange, M. B., & Lu, M. (2010)

Mass Spectrometry-Based Investigation of APP-Dependent Mechanisms in Neurodegeneration

Chaput, D. (2015) · Digital Commons - University of South Florida (University of South Florida)

Specificity of Protein Carbonylation and Its Relevance in Aging

Cabiscol, E., Tamarit, J., & Ros, J. (2017) · doi:10.1002/9781119374947.ch14

Dissecting the Molecular Mechanisms of Motor Neurone Disease in Yeast and Worms

Peswani, A. R. (2015) · Kent Academic Repository (University of Kent)

Proteomics Analysis in Alzheimer's Disease: New Insights into Mechanisms of Neurodegeneration

Butterfield, D. A., & Rukhsana Sultana, A. (2007) · Springer eBooks · doi:10.1007/978-0-387-30377-2_13

Investigation of Early Complex Formation of Huntingtin Protein With and Without Lipids

Stonebraker, A. R. (2023) · doi:10.33915/etd.11962

MOLECULAR MECHANISMS OF OLFACTORY NEURODEGENERATION

Vaishnav, R. (2007) · UKnowledge (University of Kentucky)

INVESTIGATIONS INTO MODULATION OF BRAIN OXIDATIVE STRESS BY VARIOUS INTERVENTIONS

Harris, J. L. (2012) · UKnowledge (University of Kentucky)

Potentialisation des effets de composés phénoliques combinés de l’huile d’olive : étude des transformations rédox : application dans les maladies neurodégénératives

de Malezieu, M. L. (2019) · theses.fr (ABES) · doi:10.70675/4835bd4fzaab3z4f61z9214z482e05765109

INVESTIGATIONS OF S-GLUTATHIONYLATION OF BRAIN PROTEINS IN THE PROGRESSION OF ALZHEIMER'S DISEASE AND OF A POTENTIAL GLUTATIONE MIMETIC AS A TREATMENT OF ALZHEIMER'S DISEASE

Newman, S. F. (2009) · UKnowledge (University of Kentucky)

Proteomic identification of proteins specifically oxidized in Caenorhabditis elegans expressing human A�(1–42): Implications for Alzheimer’s disease

Debra Boyd-kimball, A., Poon, H. F., Lynn, B. C., Jian Cai, D., Pierce, W. M. J., Klein, J. B., Jmil Ferguson, F., F, C. D. L., & Butterfield, D. A. (2005)

Proteomic identification of proteins specifically oxidized in C. elegans expressing human A beta (142) implications for

Debra Boyd-kimball, A., Sultana, A. R., Poon, A. H. F., Lynn, B. C., Casamenti, B. F., Pepeu, D. G., E, D. J. B. K., & Butterfield, D. A. (2013)

Proteomic identification of proteins oxidized by Aβ(1–42) in synaptosomes: Implications for Alzheimer's disease

Debra Boyd-kimball, A., Castegna, A., Rukhsana Sultana, A., Poon, H. F., Petroze, R. T., Lynn, B. C., Klein, J. B., & Butterfield, D. A. (2005) · Brain Research · doi:10.1016/j.brainres.2005.02.086 · Cited by 142 · see citing works

Proteomic identification of proteins specifically oxidized by intracerebral injection of amyloid β-peptide (1–42) into rat brain: Implications for Alzheimer’s disease

Debra Boyd-kimball, A., Rukhsana Sultana, A., Poon, H. F., Lynn, B. C., Casamenti, F., Pepeu, G., Klein, J. B., & Butterfield, D. A. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.12.022 · Cited by 166 · see citing works

Proteomic identification of proteins specifically oxidized by intracerebroventricular injection of Aß(1-42) into rat brain: implications for Alzheimer’s disease

D, B. K., Poon, H. F., Lynn, B. C., A., K. J. B. A. B. D., Casamenti, F., & PEPEU, G. (2005) · Florence Research (University of Florence)